Pre-market hot trades in US stocks: Universal Safety Products pre-market down 8.33%; Eason Tech pre-market up 7.81%

Pre-market Hot Trades in US Stocks Universal Safety Products, down 8.33% in pre-market, has no significant news recently. Trading is active with clear capital flow, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Eason Tech is up 7.81% in pre-market. Based on recent news, On January 9, Eason Technology Limited announced the signing of a purchase agreement to acquire a commercial property in Hubei for approximately RMB 24.6 million (USD 3.5 million). This acquisition reflects the company's strategic expansion plan aimed at strengthening its presence in the real estate sector and capitalizing on development and revenue opportunities in the region. Following this announcement, the market expressed optimism about the company's future growth prospects, driving the stock price up. On January 9, Eason Technology Limited issued a forward-looking statement emphasizing the company's capabilities in managing growth, identifying and integrating future acquisitions, and obtaining additional financing. Although the statement mentioned some potential risks and uncertainties, the overall market held a positive attitude towards the company's development prospects, further boosting the stock price. On January 9, Eason Technology Limited released the above news via PR Newswire, further enhancing market confidence in the company's strategic expansion and growth potential, leading to a significant increase in stock price during pre-market trading. The real estate industry has performed strongly recently, with a stable macroeconomic environment. Top Gainers in Pre-market US Stocks AlphaTON Capital, up 142.86% in pre-market, has no significant news recently. Trading is active with clear capital flow, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. BriaCell is up 74.48% in pre-market. Based on recent news: On January 13, BriaCell Therapeutics announced significant progress with its investigational drug, leading to a substantial increase in stock price. The company detailed the clinical trial results of the drug in an announcement published via GlobeNewswire, which triggered a positive market reaction, pushing the stock price up 74.48% in pre-market. There are no other significant news recently. The biotechnology industry has performed strongly lately, with noticeable capital inflow. Ambitions Enterprise is up 63.64% in pre-market, with no significant news recently. Trading is active with clear capital flow, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation